Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	43.56	62.55	43.57
Graham Fair Price	7.42	47.33	44.07
PEG	116.45	1.86	-0.86
Price/Book	7.34	2.61	2.43
Price/Cash Flow	106.67	67.89	32.85
Prices/Earnings	-3.62	24.91	25.85
Price/Sales	19.00	9.31	7.82
Price/FCF	106.67	67.89	32.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.82	0.35	0.37
Operating Margin	-24.10	0.15	0.20
ROA	13.08	0.01	0.01
ROE	0.02	0.03	11.37
ROIC	0.03	0.02	-40.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.02	-143.59
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.16	-0.30	92.17
EPS QOQ	-0.30	0.13	-55.47
FCF QOQ	0.21	-0.47	120.04
Revenue QOQ	0.03	-0.08	184.29
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	131.56	142.03	7.96
Days Sales Outstanding (DSO)	61.72	63.60	3.05
Inventory Turnover	0.68	0.63	-7.38
Debt/Capitalization	0.43	0.42	-1.32
Quick Ratio	1.11	1.19	7.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	60.63	61.71	1.79
Cash	4.67	6.39	36.71
Capex	-0.29	-0.26	11.10
Free Cash Flow	4.48	2.37	-47.14
Revenue	18.82	17.28	-8.19
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.31	2.40	4.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.81	12.24	24.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating